
Bernstein Liebhard LLP reminds Boston Scientific investors of a May 4, 2026 deadline to join a securities fraud class action lawsuit. The suit alleges misrepresentations about Boston Scientific’s U.S. electrophysiology segment, covering stock purchases between July 23, 2025 and February 3, 2026. Investors who lost money during this period may be eligible to participate without paying fees unless they choose to serve as lead plaintiff. The law firm has a strong track record in investor litigation and encourages affected shareholders to contact them for legal options.